| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.32B | 47.76B | 44.28B | 38.42B | 35.38B | 30.41B |
| Gross Profit | 12.73B | 11.94B | 13.72B | 11.66B | 9.04B | 6.59B |
| EBITDA | 11.79B | 12.66B | 15.04B | 13.85B | 11.15B | 8.09B |
| Net Income | 8.71B | 8.83B | 8.82B | 8.75B | 6.81B | 4.75B |
Balance Sheet | ||||||
| Total Assets | 94.62B | 91.08B | 92.34B | 88.47B | 78.52B | 62.77B |
| Cash, Cash Equivalents and Short-Term Investments | 26.52B | 25.68B | 22.31B | 19.79B | 17.45B | 12.72B |
| Total Debt | 18.87B | 11.48B | 17.35B | 15.44B | 13.12B | 4.44B |
| Total Liabilities | 29.76B | 23.90B | 29.67B | 28.18B | 24.05B | 13.84B |
| Stockholders Equity | 64.20B | 66.43B | 62.06B | 59.80B | 54.03B | 48.64B |
Cash Flow | ||||||
| Free Cash Flow | 2.32B | 5.89B | 5.53B | 6.69B | 4.07B | -2.11B |
| Operating Cash Flow | 10.45B | 11.97B | 11.43B | 13.36B | 11.48B | 7.22B |
| Investing Cash Flow | -3.26B | -4.83B | -5.98B | -12.25B | -16.04B | -8.76B |
| Financing Cash Flow | -4.40B | -10.57B | -5.00B | -769.84M | 7.06B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $18.75B | 11.18 | 14.02% | 2.98% | 11.11% | 4.25% | |
76 Outperform | $20.49B | 20.83 | 36.71% | 1.02% | 1.13% | 2.62% | |
71 Outperform | $23.14B | 35.63 | 17.30% | 0.89% | 0.58% | 17.20% | |
67 Neutral | $90.33B | 22.26 | 15.76% | 1.94% | 4.69% | 17.55% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | $20.20B | 33.78 | 33.32% | 1.51% | -6.68% | 18.19% | |
58 Neutral | $85.66B | 24.20 | 33.03% | 6.55% | -2.59% | -9.78% |